Solasia Pharma K.K.
In-licenses and commercializes oncology treatments and supportive care products in Asia.
4597 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 港区芝公園二丁目１１番１号
- Website:
- https://solasia.co.jp/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Solasia Pharma K.K. is a specialty pharmaceutical company focused on developing and commercializing innovative oncology products to address unmet medical needs in Japan and other Asian countries. The company's business model centers on in-licensing promising drug candidates and medical devices, primarily from the US and Europe. Its portfolio includes approved therapies for cancer treatment, such as Peripheral T-Cell Lymphoma, and supportive care solutions for managing treatment side effects like chemotherapy-induced nausea and vomiting (CINV) and oral mucositis. Solasia's development pipeline targets conditions including colorectal cancer and chemotherapy-induced peripheral neuropathy. The company leverages its small, expert team for quick and flexible decision-making to efficiently bring new treatments to market.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Solasia Pharma K.K. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-13 08:43 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2025-08-13 08:42 |
Interim Report
半期報告書－第18期(2025/01/01－2025/12/31)
|
Japanese | 228.0 KB | |
| 2025-03-31 08:49 |
Regulatory News Service
訂正有価証券届出書（組込方式）
|
Japanese | 147.2 KB | |
| 2025-03-31 08:43 |
Regulatory News Service
臨時報告書
|
Japanese | 23.8 KB | |
| 2025-03-26 07:30 |
Registration Form
訂正有価証券届出書（組込方式）
|
Japanese | 181.4 KB | |
| 2025-03-26 07:21 |
Regulatory News Service
内部統制報告書－第17期(2024/01/01－2024/12/31)
|
Japanese | 22.7 KB | |
| 2025-03-26 07:20 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2025-03-26 07:19 |
Annual Report
有価証券報告書－第17期(2024/01/01－2024/12/31)
|
Japanese | 1.1 MB | |
| 2025-03-24 07:37 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 263.8 KB | |
| 2025-03-10 07:31 |
Regulatory News Service
臨時報告書
|
Japanese | 19.5 KB | |
| 2024-08-14 08:43 |
Report Publication Announcement
確認書
|
Japanese | 8.1 KB | |
| 2024-08-14 08:42 |
Interim Report
半期報告書－第17期(2024/01/01－2024/12/31)
|
Japanese | 238.4 KB | |
| 2024-05-15 08:42 |
Report Publication Announcement
確認書
|
Japanese | 8.1 KB | |
| 2024-05-15 08:40 |
Quarterly Report
四半期報告書－第17期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 219.9 KB | |
| 2024-03-26 07:08 |
Regulatory News Service
臨時報告書
|
Japanese | 22.8 KB |
Automate Your Workflow. Get a real-time feed of all Solasia Pharma K.K. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Solasia Pharma K.K. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
